BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pereira-Veiga T, González-Conde M, León-Mateos L, Piñeiro-Cid R, Abuín C, Muinelo-Romay L, Martínez-Fernández M, Brea Iglesias J, García González J, Anido U, Aguín-Losada S, Cebey V, Costa C, López-López R. Longitudinal CTCs gene expression analysis on metastatic castration-resistant prostate cancer patients treated with docetaxel reveals new potential prognosis markers. Clin Exp Metastasis 2021;38:239-51. [PMID: 33635497 DOI: 10.1007/s10585-021-10075-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Kemp JA, Kwon YJ. Cancer nanotechnology: current status and perspectives. Nano Converg 2021;8:34. [PMID: 34727233 DOI: 10.1186/s40580-021-00282-7] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Flores BCT, Correia MP, Rodríguez JG, Henrique R, Jerónimo C. Bridging the Gaps between Circulating Tumor Cells and DNA Methylation in Prostate Cancer. Cancers (Basel) 2021;13:4209. [PMID: 34439363 DOI: 10.3390/cancers13164209] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Gurioli G, Conteduca V, Brighi N, Scarpi E, Basso U, Fornarini G, Mosca A, Nicodemo M, Banna GL, Lolli C, Schepisi G, Ravaglia G, Bondi I, Ulivi P, De Giorgi U. Circulating tumor cell gene expression and plasma AR gene copy number as biomarkers for castration-resistant prostate cancer patients treated with cabazitaxel. BMC Med 2022;20:48. [PMID: 35101049 DOI: 10.1186/s12916-022-02244-0] [Reference Citation Analysis]